Basilea Pharmaceutica AG (0QNA.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 671.07M |
| Enterprise Value | 730.64M |
| P/E Ratio | 15.16 |
| PEG Ratio | -1.25 |
| Price/Sales Ratio | 3.23 |
| Price/Book Ratio | 4.92 |
| Enterprise/Revenue | 2.86 |
| Enterprise/EBITDA | 11.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.21 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.18 |
| Return On Equity | 0.36 |
Income Statement
| Revenue | 232.4M |
| Revenue/Share | 20 |
| Gross Profit | 193.1M |
| EBITDA | 55.26M |
| Net Income | 40.2M |
| Diluted EPS | 3.14 |
Balance Sheet
| Total Cash | 175.98M |
| Total Cash/Share | 14.23 |
| Total Debt | 83.44M |
| Total Debt/Equity | 0.51 |
| Current Ratio | 6.6 |
| Book Value Per Share | 13.12 |
Price History
| 52-Week Change | 37.07 |
| 52-Week High | 65.9 |
| 52-Week Low | 32.2 |
| Moving Average 50 Days | 35.23 |
| Moving Average 200 Days | 39.55 |
Statistics
| Average Volume | 4,885 |
| Shares Outstanding | 12.29M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
